CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 12,287,228	$ 15,215,285
Accounts receivable, net of allowance of $40,831 and $330,853 at March 31, 2023 and September 30, 2022, respectively	1,967,710	3,067,544
Inventories	366,085	602,244
Prepaid expenses and other current assets	758,530	1,058,056
Total current assets	15,379,553	19,943,129
Property and equipment, net	1,575,309	2,222,988
Other assets:
Restricted cash	750,000
Right of use asset	1,470,615
Deposits		98,997
Total assets	19,175,477	22,265,114
Current liabilities:
Accounts payable and accrued liabilities	2,895,578	3,621,751
Lease liability, current	476,502
Deferred revenue	283,298	563,557
Total current liabilities	3,655,378	4,185,308
Long term accrued liabilities	31,467	31,467
Lease liability, long term	994,111
Warrants classified as a liability	4,526,300	5,139,400
Total liabilities	9,207,256	9,356,175
Commitments and contingencies
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively	0	0
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of March 31, 2023 and September 30, 2022, 12,908,520 shares issued and outstanding as of March 31, 2023 and September 30, 2022	12,909	12,909
Additional paid in capital	305,751,360	305,399,008
Accumulated deficit	(295,755,117)	(292,500,088)
Applied DNA Sciences, Inc. stockholders' equity	10,009,152	12,911,829
Noncontrolling interest	(40,931)	(2,890)
Total equity	9,968,221	12,908,939
Total liabilities and equity	19,175,477	22,265,114
Series A Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively	0	0
Series B Preferred stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of March 31, 2023 and September 30, 2022, respectively	$ 0	$ 0